115 related articles for article (PubMed ID: 38582634)
21. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
Awasthi R; Rathore RK; Soni P; Sahoo P; Awasthi A; Husain N; Behari S; Singh RK; Pandey CM; Gupta RK
Neuroradiology; 2012 Mar; 54(3):205-13. PubMed ID: 21541688
[TBL] [Abstract][Full Text] [Related]
22. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
23. Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.
Zhang Y; Kapur P; Yuan Q; Xi Y; Carvo I; Signoretti S; Dimitrov I; Cadeddu JA; Margulis V; Muradyan N; Brugarolas J; Madhuranthakam AJ; Pedrosa I
Clin Genitourin Cancer; 2016 Feb; 14(1):e25-36. PubMed ID: 26422014
[TBL] [Abstract][Full Text] [Related]
24. The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.
Yuan SJ; Qiao TK; Qiang JW; Cai SQ; Li RK
J Ovarian Res; 2017 Sep; 10(1):65. PubMed ID: 28950890
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.
Jiang JS; Hua Y; Zhou XJ; Shen DD; Shi JL; Ge M; Geng QN; Jia ZZ
Acad Radiol; 2019 Sep; 26(9):1215-1221. PubMed ID: 30416002
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
27. Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.
Huang Z; Xu X; Meng X; Hou Z; Liu F; Hua Q; Liu Q; Xiu J
Eur J Radiol; 2015 Dec; 84(12):2464-9. PubMed ID: 26456310
[TBL] [Abstract][Full Text] [Related]
28. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.
Yopp AC; Schwartz LH; Kemeny N; Gultekin DH; Gönen M; Bamboat Z; Shia J; Haviland D; D'Angelica MI; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR
Ann Surg Oncol; 2011 Aug; 18(8):2192-9. PubMed ID: 21286939
[TBL] [Abstract][Full Text] [Related]
31. Preliminary MRI Study of Extracellular Volume Fraction for Identification of Lymphovascular Space Invasion of Cervical Cancer.
Wang W; Fan X; Yang J; Wang X; Gu Y; Chen M; Jiang Y; Liu L; Zhang M
J Magn Reson Imaging; 2023 Feb; 57(2):587-597. PubMed ID: 36094153
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.
Ma L; Xu X; Zhang M; Zheng S; Zhang B; Zhang W; Wang P
Magn Reson Imaging; 2017 Apr; 37():27-32. PubMed ID: 27840273
[TBL] [Abstract][Full Text] [Related]
33. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
34. Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Can Differentiate Between Atypical Cartilaginous Tumors and High-Grade Chondrosarcoma: Correlation With Histological Vessel Characteristics.
Jin B; Yang J; Zhen J; Xu Y; Wang C; Jing Q; Shang Y
J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):123-128. PubMed ID: 37558644
[TBL] [Abstract][Full Text] [Related]
35. Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN, P-Akt and m-TOR in different pathological types of lung cancer.
Zhang B; Zhao Z; Huang Y; Mao H; Zou M; Wang C; Yu G; Zhang M
BMC Med Imaging; 2021 Apr; 21(1):73. PubMed ID: 33865336
[TBL] [Abstract][Full Text] [Related]
36. A study of dynamic contrast-enhanced MR imaging features and influence factors of pelvic bone marrow in adult females.
Zhang X; Pang H; Dong Y; Shi D; Liu F; Luo Y; Yu T; Wang X
Osteoporos Int; 2019 Dec; 30(12):2469-2476. PubMed ID: 31451839
[TBL] [Abstract][Full Text] [Related]
37. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
[TBL] [Abstract][Full Text] [Related]
39. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
[TBL] [Abstract][Full Text] [Related]
40. Expression of hypoxia-inducible factor-1α and -2α in whole-mount prostate histology: relation with dynamic contrast-enhanced MRI and Gleason score.
Borren A; Groenendaal G; van der Groep P; Moman MR; Boeken Kruger AE; van der Heide UA; Jonges TN; van Diest PJ; van Vulpen M; Philippens ME
Oncol Rep; 2013 Jun; 29(6):2249-54. PubMed ID: 23588703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
